1259391-10-0

Basic information

• Product Name: N-((5-((R)-2-benzyl-3-((S)-4-benzyl-2-oxo-oxazolidin-3-yl)-3-oxopropyl)-2-propoxyphenyl)methyl)-4-(1-adamantanyl)benzamide
• Synonyms: N-((5-((R)-2-benzyl-3-((S)-4-benzyl-2-oxo-oxazolidin-3-yl)-3-oxopropyl)-2-propoxyphenyl)methyl)-4-(1-adamantanyl)benzamide
• CAS NO: 1259391-10-0
• Molecular Weight: 724.94
• Mol File: 1259391-10-0.mol

Chemical Properties

• CAS DataBase Reference: N-((5-((R)-2-benzyl-3-((S)-4-benzyl-2-oxo-oxazolidin-3-yl)-3-oxopropyl)-2-propoxyphenyl)methyl)-4-(1-adamantanyl)benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-((5-((R)-2-benzyl-3-((S)-4-benzyl-2-oxo-oxazolidin-3-yl)-3-oxopropyl)-2-propoxyphenyl)methyl)-4-(1-adamantanyl)benzamide(1259391-10-0)
• EPA Substance Registry System: N-((5-((R)-2-benzyl-3-((S)-4-benzyl-2-oxo-oxazolidin-3-yl)-3-oxopropyl)-2-propoxyphenyl)methyl)-4-(1-adamantanyl)benzamide(1259391-10-0)

Safety Data

• Hazardous Substances Data: 1259391-10-0(Hazardous Substances Data)

Upstream product

• 1259391-06-4 benzyl 5-bromomethyl-2-propoxybenzoate 
• 1259391-07-5 benzyl 5-((R)-2-benzyl-3-((S)-4-benzyl-2-oxo-oxazolidin-3-yl)-3-oxopropyl)-2-propoxybenzoate 
• 1259391-08-6 5-((R)-2-benzyl-3-((S)-4-benzyl-2-oxo-oxazolidin-3-yl)-3-oxopropyl)-2-propoxybenzoic acid 
• 1259391-09-7 5-((R)-2-benzyl-3-((S)-4-benzyl-2-oxo-oxazolidin-3-yl)-3-oxopropyl)-2-propoxy-benzaldehyde 
• 117101-74-3 4-(1-adamantyl)benzamide 
• 1259391-16-6 C₃₀H₃₃NO₅ 
• 1259391-04-2 benzyl 2-propoxy-5-formylsalicylate 
• 1259391-05-3 benzyl 5-hydroxymethyl-2-propoxybenzoate 
• 616-76-2 2-hydroxy-5-formylbenzoic acid 
• 176047-66-8 benzyl 2-hydroxy-5-formylbenzoate 

Downstream Products

• 1259391-03-1 (R)-2-((3-(((4-(1-adamantyl)benzoyl)amino)methyl)-4-propoxyphenyl)methyl)-3-cyclohexylpropanoic acid 

Relevant articles and documents

Design, synthesis, and structural analysis of phenylpropanoic acid-type PPARγ-selective agonists: Discovery of reversed stereochemistry-activity relationship

Peroxisome proliferator-activated receptor gamma (PPARγ) is a ligand-mediated transcription factor with roles in glucose, lipid, and lipoprotein homeostasis, and PPARγ ligands are expected have therapeutic potential in these as well as other areas. We rep